Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation
Open Access
- 2 September 2014
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 179 (2) , 300-308
Abstract
Evidence exists that interleukin (IL)‐10 family cytokines may be involved in the pathogenesis of rheumatoid arthritis (RA). We sought to determine whether or not these cytokines are involved in psoriatic arthritis (PsA). We conducted a prospective study on patients with PsA, RA and osteoarthritis (OA); healthy controls (HC) were also included. We analysed IL‐20, IL‐24 and IL‐19 serum and synovial fluid (SF) levels and change of serum levels following treatment with biological agents. IL‐20 serum levels were increased in PsA and RA compared with OA patients and HC and with matched SF levels. IL‐24 serum levels in PsA, RA and OA patients were higher than those in HC and also with respect to matched SF in PsA. IL‐19 serum levels were higher in HC and OA compared with PsA and RA patients; IL‐19 SF levels were higher in PsA and RA compared with OA patients, and in PsA compared with RA patients. PsA and RA patients showed a reduction of IL‐19 serum levels after biological treatment. Therefore, IL‐19 seems to be involved mainly in the joint inflammation, whereas IL‐20 and IL‐24 appear to participate mainly in the systemic responses. These findings may further the comprehension of the contribution of these cytokines to the inflammatory response involved in chronic arthritis, as well as to the development of novel therapeutic strategies.Keywords
This publication has 31 references indexed in Scilit:
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012Annals of the Rheumatic Diseases, 2013
- Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatmentArthritis Research & Therapy, 2012
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factorArthritis & Rheumatism, 2011
- IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseasesExpert Opinion on Therapeutic Targets, 2010
- Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the jointsScandinavian Journal of Rheumatology, 2009
- Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formationRheumatology, 2008
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Evaluation of the role of cytokines in autoimmune disease: The importance of TNFα in rheumatoid arthritisProgress in Growth Factor Research, 1992
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988